Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

Robert Paul Liberman, Theodore Van Putten, Barringer D. Marshall, Jim Mintz, Linda Bowen, Timothy G. Kuehnel, Manickan Aravagiri, Stephen R. Marder

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

Original languageEnglish (US)
Pages (from-to)756-759
Number of pages4
JournalAmerican Journal of Psychiatry
Volume151
Issue number5
StatePublished - May 1994
Externally publishedYes

Fingerprint

Behavior Therapy
Haloperidol
Drug Therapy
Interpersonal Relations
Self Care
Psychopathology
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Liberman, R. P., Van Putten, T., Marshall, B. D., Mintz, J., Bowen, L., Kuehnel, T. G., ... Marder, S. R. (1994). Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. American Journal of Psychiatry, 151(5), 756-759.

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. / Liberman, Robert Paul; Van Putten, Theodore; Marshall, Barringer D.; Mintz, Jim; Bowen, Linda; Kuehnel, Timothy G.; Aravagiri, Manickan; Marder, Stephen R.

In: American Journal of Psychiatry, Vol. 151, No. 5, 05.1994, p. 756-759.

Research output: Contribution to journalArticle

Liberman, RP, Van Putten, T, Marshall, BD, Mintz, J, Bowen, L, Kuehnel, TG, Aravagiri, M & Marder, SR 1994, 'Optimal drug and behavior therapy for treatment-refractory schizophrenic patients', American Journal of Psychiatry, vol. 151, no. 5, pp. 756-759.
Liberman RP, Van Putten T, Marshall BD, Mintz J, Bowen L, Kuehnel TG et al. Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. American Journal of Psychiatry. 1994 May;151(5):756-759.
Liberman, Robert Paul ; Van Putten, Theodore ; Marshall, Barringer D. ; Mintz, Jim ; Bowen, Linda ; Kuehnel, Timothy G. ; Aravagiri, Manickan ; Marder, Stephen R. / Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. In: American Journal of Psychiatry. 1994 ; Vol. 151, No. 5. pp. 756-759.
@article{ed2b1f249fc64921a123cfdc24f166a3,
title = "Optimal drug and behavior therapy for treatment-refractory schizophrenic patients",
abstract = "Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63{\%} with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.",
author = "Liberman, {Robert Paul} and {Van Putten}, Theodore and Marshall, {Barringer D.} and Jim Mintz and Linda Bowen and Kuehnel, {Timothy G.} and Manickan Aravagiri and Marder, {Stephen R.}",
year = "1994",
month = "5",
language = "English (US)",
volume = "151",
pages = "756--759",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "5",

}

TY - JOUR

T1 - Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

AU - Liberman, Robert Paul

AU - Van Putten, Theodore

AU - Marshall, Barringer D.

AU - Mintz, Jim

AU - Bowen, Linda

AU - Kuehnel, Timothy G.

AU - Aravagiri, Manickan

AU - Marder, Stephen R.

PY - 1994/5

Y1 - 1994/5

N2 - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

AB - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

UR - http://www.scopus.com/inward/record.url?scp=0028202507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028202507&partnerID=8YFLogxK

M3 - Article

C2 - 8166320

AN - SCOPUS:0028202507

VL - 151

SP - 756

EP - 759

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 5

ER -